Kang W - Search Results

1

Silencing of hypoxia-inducible factor-1β induces anti-tumor effects in hepatoma cell lines under tumor hypoxia.

Choi SH, Chung AR, Kang W, Park JY, Lee MS, Hwang SW, Kim DY, Kim SU, Ahn SH, Kim S, Han KH. Choi SH, et al. Among authors: kang w. PLoS One. 2014 Jul 28;9(7):e103304. doi: 10.1371/journal.pone.0103304. eCollection 2014. PLoS One. 2014. PMID: 25068796 Free PMC article.

2

Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis.

Kim SU, Ahn SH, Park JY, Kang W, Kim DY, Park YN, Chon CY, Han KH. Kim SU, et al. Among authors: kang w. J Clin Gastroenterol. 2009 Mar;43(3):267-71. doi: 10.1097/MCG.0b013e31816f212e. J Clin Gastroenterol. 2009. PMID: 18987556

3

Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD.

Kang W, Kim SU. Kang W, et al. Clin Mol Hepatol. 2013 Sep;19(3):255-7. doi: 10.3350/cmh.2013.19.3.255. Epub 2013 Sep 30. Clin Mol Hepatol. 2013. PMID: 24133662 Free PMC article. No abstract available.

4

Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions.

Kang W, Sung PS, Park SH, Yoon S, Chang DY, Kim S, Han KH, Kim JK, Rehermann B, Chwae YJ, Shin EC. Kang W, et al. Gastroenterology. 2014 May;146(5):1351-60.e1-4. doi: 10.1053/j.gastro.2014.01.054. Epub 2014 Jan 31. Gastroenterology. 2014. PMID: 24486950 Free PMC article.

5

Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen-positive chronic hepatitis B patients.

Lee HW, Kang W, Ahn SH, Lee HJ, Hwang JS, Sohn JH, Jang JY, Han KJ, Kim JK, Kim DY, Paik YH, Lee CK, Choi IS, Lee KS, Han KH. Lee HW, et al. Among authors: kang w. J Gastroenterol Hepatol. 2014 May;29(5):1049-55. doi: 10.1111/jgh.12522. J Gastroenterol Hepatol. 2014. PMID: 24575848

6

Non-invasive prediction of forthcoming cirrhosis-related complications.

Kang W, Kim SU, Ahn SH. Kang W, et al. World J Gastroenterol. 2014 Mar 14;20(10):2613-23. doi: 10.3748/wjg.v20.i10.2613. World J Gastroenterol. 2014. PMID: 24627597 Free PMC article. Review.

7

When to stop nucleos(t)ide analogues treatment for chronic hepatitis B? Durability of antiviral response.

Kang W, Park JY. Kang W, et al. World J Gastroenterol. 2014 Jun 21;20(23):7207-12. doi: 10.3748/wjg.v20.i23.7207. World J Gastroenterol. 2014. PMID: 24966590 Free PMC article. Review.

8

Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B.

Park MS, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Shin SH, Kang W, Moon C, Han KH. Park MS, et al. Among authors: kang w. Liver Int. 2015 Feb;35(2):455-62. doi: 10.1111/liv.12678. Epub 2014 Oct 10. Liver Int. 2015. PMID: 25183426 Clinical Trial.

9

A case of autoimmune hepatitis combined with Graves' disease.

Jhee JH, Kim HJ, Kang W, Kim S, Kim DY. Jhee JH, et al. Among authors: kang w. Korean J Gastroenterol. 2015 Jan;65(1):48-51. doi: 10.4166/kjg.2015.65.1.48. Korean J Gastroenterol. 2015. PMID: 25603854 Free article.

10

Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B.

Lee HW, Kang W, Kim BK, Kim SU, Park JY, Kim DY, Ahn SH, Park YN, Han KH. Lee HW, et al. Among authors: kang w. Liver Int. 2016 Jan;36(1):24-30. doi: 10.1111/liv.12868. Epub 2015 May 31. Liver Int. 2016. PMID: 25966326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,521 results

Search Page

Filters